Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ProCaLung - Project on Cancer of the Lung : A National Radiotherapy Quality Assurance for Stage III NSCLC

NCT04726358 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.

NCT NCT04726358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04726358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ProCaLung - Project on Cancer of the Lung : A National Radiotherapy Quality Assurance for Stage III NSCLC
Lead sponsor
Jules Bordet Institute
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2021
Completion date
March 1, 2025
Enrollment
1,000 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced lung carcinoma